Moderna Therapeutics' Series C Round

Moderna Therapeutics raised a round of funding on November 20, 2013.

Moderna Therapeutics is pioneering messenger RNA Therapeutics, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracell…

Articles about Moderna Therapeutics' Series C Round: